181 related articles for article (PubMed ID: 36006857)
1. Mass Spectrometric Quantitation of
Li Y; Hecht SS
Chem Res Toxicol; 2022 Sep; 35(9):1579-1588. PubMed ID: 36006857
[No Abstract] [Full Text] [Related]
2. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
Hecht SS; Stepanov I; Carmella SG
Acc Chem Res; 2016 Jan; 49(1):106-14. PubMed ID: 26678241
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users.
Kotandeniya D; Carmella SG; Pillsbury ME; Hecht SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Dec; 1007():121-6. PubMed ID: 26595795
[TBL] [Abstract][Full Text] [Related]
4. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
Stepanov I; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
Trushin N; Hecht SS
Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
[TBL] [Abstract][Full Text] [Related]
7. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
Yuan JM; Knezevich AD; Wang R; Gao YT; Hecht SS; Stepanov I
Carcinogenesis; 2011 Sep; 32(9):1366-71. PubMed ID: 21734256
[TBL] [Abstract][Full Text] [Related]
8. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users.
Stepanov I; Carmella SG; Han S; Pinto A; Strasser AA; Lerman C; Hecht SS
Nicotine Tob Res; 2009 Jan; 11(1):99-105. PubMed ID: 19246447
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry-Based Metabolic Profiling of Urinary Metabolites of
Li Y; Dator RP; Maertens LA; Balbo S; Hecht SS
Chem Res Toxicol; 2023 May; 36(5):769-781. PubMed ID: 37017527
[TBL] [Abstract][Full Text] [Related]
10. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
[TBL] [Abstract][Full Text] [Related]
11. Analysis of N'-nitrosonornicotine enantiomers in human urine by chiral stationary phase liquid chromatography-nanoelectrospray ionization-high resolution tandem mass spectrometry.
Yang J; Carmella SG; Hecht SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():127-131. PubMed ID: 28107699
[TBL] [Abstract][Full Text] [Related]
12. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
Tyroller S; Zwickenpflug W; Thalheim C; Richter E
Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
[TBL] [Abstract][Full Text] [Related]
13. An update on the formation in tobacco, toxicity and carcinogenicity of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Peterson LA; Stanfill SB; Hecht SS
Carcinogenesis; 2024 May; 45(5):275-287. PubMed ID: 38437625
[TBL] [Abstract][Full Text] [Related]
14. Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines.
Upadhyaya P; McIntee EJ; Hecht SS
Chem Res Toxicol; 2001 May; 14(5):555-61. PubMed ID: 11368554
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
[TBL] [Abstract][Full Text] [Related]
16. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters.
Hoffmann D; Castonguay A; Rivenson A; Hecht SS
Cancer Res; 1981 Jun; 41(6):2386-93. PubMed ID: 7237437
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
Staretz ME; Murphy SE; Patten CJ; Nunes MG; Koehl W; Amin S; Koenig LA; Guengerich FP; Hecht SS
Drug Metab Dispos; 1997 Feb; 25(2):154-62. PubMed ID: 9029045
[TBL] [Abstract][Full Text] [Related]
18. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
19. It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco.
Hecht SS
Cancer Prev Res (Phila); 2014 Jul; 7(7):639-47. PubMed ID: 24806664
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometric Quantitation of Apurinic/Apyrimidinic Sites in Tissue DNA of Rats Exposed to Tobacco-Specific Nitrosamines and in Lung and Leukocyte DNA of Cigarette Smokers and Nonsmokers.
Guo J; Chen H; Upadhyaya P; Zhao Y; Turesky RJ; Hecht SS
Chem Res Toxicol; 2020 Sep; 33(9):2475-2486. PubMed ID: 32833447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
